• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Hydroxysteroid Dehydrogenase, 11-Beta, Type I (HSD11B2) Enzyme

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS653798

Synthetic peptide corresponding to 16aa of mouse 11b-HSD1 conjugated to KLH.11-Beta-hydroxysteroid dehydrogenase (11b-HSD) is a microsomal short chain dehydrogenase/reductase (SDR) which catalyzes the inter-conversion of biologically active glucocorticoid… More details

$610 / 0.1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Hydroxysteroid Dehydrogenase, 11-beta, Type I (HSD11B2), Enzyme
Full Product Name
Hydroxysteroid Dehydrogenase, 11-beta, Type I Mouse (11b-HSD1) Control Peptide
Product Gene Name
Form/Format
Supplied as a lyophilized powder from PBS. Reconstitute with 100ul sterile PBS
Purity/Purification
Highly purified
Concentration
~1 mg/ml (After Reconstitution) (lot specific)
Specificity
Synthetic peptide 16aa mapping near the N-terminus of mouse 11b-HSD1. No significant sequence homology is seen with 11b-HSD2 or other proteins. Species sequence homology
Preparation and Storage
Lyophilized and reconstituted prodcuts are stable for 6 months after receipt at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight
< 3kD
Chromosome Location
Chromosome: 16; NC_000016.9 (67465036..67471456). Location: 16q22
OMIM
218030
3D Structure
ModBase 3D Structure for P80365
Source
Mouse
Species sequence homology
100% conserved in the mouse and rat, 87% in sheep and 81% in human and chicken, 75% in porcine and 68% in rabbit 11b-HSD1. No significant sequence homology is seen with other proteins. Control peptide for MBS625504(antiserum)or per 1ug MBS625247 (affintity purified antibody)
Applications Tested/Suitable for HSD11B2 enzyme
ELISA (EL/EIA) and Antibody blocking. Not suitable for use in Western Blot.
Other applications not tested.
Application Notes for HSD11B2 enzyme
ELISA: 50-100ng/well
Antibody Blocking: 5-10ug control peptide per 1ul MBS625504(antiserum)or per 1ug MBS625247 (affintity purified antibody).
Optimal dilutions to be determined by the researcher.

Antibody Blocking -
Principle: It is not uncommon to see more than 1 band in Western Blot when probed with a given antibody or see more diffuse staining in immuno-localization studies. The question arises which one of this band(s)/staining is specific. The antibody specificity is generally studied by competing with excess of antigen (peptide or protein) or immuno-neutralization with the antigens. ln principle, a small volume of antibodv (e.g. 1-5ul) is first reacted with excess peptide (5-50 fold over the antibodv e.g. 1 ug antibody reacted with 5-50ug peptide; exact amounts determined by titration) to neutralize it. The neutralized antibody can no longer subsequently bind to another antigen (a band of interest) or staining pattern. So the band(s)/staining that is competed bv the antigen/peptide is supposedly specific. lf more than one band disappears by peptide/antigen competition then those bands have the antigenic determinants and could be considered either fragments of the large antigen or multimer.

General Protocol for Antibody Blocking:
1. Determine the amount of antibody that is-needed for 1 strip (e.g. 2ml). For example. an antibody has given desired bands at 1:1000 dilution. So you will need 1ul/ml antibody (2ul antibody for 2ml antibody solution). lf an antibody were used at 1:5000 dilution then you would only need 0.2ul/ml (use 2ul of 1:10 dilution for better acturacy).
2. Prepare 2 tubes
2a. Label Tube 1 as "+peptide". Label Tube 2 as "-peptide".
2b. To Tube 1, add antigen/peptide solution (10-50ug peptide or 10-100ul antigen added).
2c. To Tube 2, add same volume PBS (no peptide/antigen) to the other tube. Mix gently.
3. Incubate both tubes at 37°C for 1-2 hrs and 2-24 hrs at 4°C.
4. Centrifuge the tubes for 15 min at 4°C in a microfuge (10-15000rpm) to pellet any immune complexes. Carefully remove the supernatant. lf no visible pellet is seen, then just leave approx. 5-10ul at the bottom to avoid disturbing invisible immune complexes. If you do not centrifuge the solution, it may give high background.
5. After centrifugation, make up the volume of supernatant to 2ml (or what is necessary depending upon the initial antibody taken) with buffer (PBS, Tween with or without BSA or milk or any buffer that was used initially). Use both antibodies (with and without antigen/peptide) for Western Blot or immuno-localization.
6. Observe the bands/staining that disappear.

Notes:
1. The greater the antibody titer or initial volume of antibody taken, the greater will be the antigen/peptide necessary to completely block the antibody activity.
2. A partial inhibition of antibody activity is an indication that more antigen/peptide will be needed to completely block the antibody.
3. It may be necessary to optimize the amount of antigen/peptides by adding various amounts to a fixed concentration of antibody.

Other Notes

Small volumes of HSD11B2 enzyme vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for HSD11B2 purchase

MBS653798 is an enzyme targeting HSD11B2. Also known as Hydroxysteroid Dehydrogenase, 11-beta, Type I Mouse (11b-HSD1) Control Peptide.

Additional Details

NCBI/Uniprot data below describe general gene information for HSD11B2. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Hydroxysteroid (11-beta) dehydrogenase 2
NCBI Official Synonym Full Names
hydroxysteroid (11-beta) dehydrogenase 2
NCBI Official Symbol
HSD11B2
NCBI Official Synonym Symbols
AME; AME1; HSD2; HSD11K; SDR9C3
UniProt Protein Name
Corticosteroid 11-beta-dehydrogenase isozyme 2
UniProt Synonym Protein Names
11-beta-hydroxysteroid dehydrogenase type 2; 11-DH2; 11-beta-HSD2; 11-beta-hydroxysteroid dehydrogenase type II; -HSD11 type II; NAD-dependent 11-beta-hydroxysteroid dehydrogenase
UniProt Gene Name
HSD11B2
UniProt Synonym Gene Names
HSD11K; 11-DH2; 11-beta-HSD2; -HSD11 type II; 11-beta-HSD
UniProt Entry Name
DHI2_HUMAN
NCBI Protein Information
corticosteroid 11-beta-dehydrogenase isozyme 2; 11-DH2; 11-beta-HSD2; -HSD11 type II; 11-beta-hydroxysteroid dehydrogenase type 2; 11-beta-hydroxysteroid dehydrogenase type II; NAD-dependent 11-beta-hydroxysteroid dehydrogenase; short chain dehydrogenase/reductase family 9C member 3

NCBI Summary for HSD11B2

There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]
Show more

UniProt Comments for HSD11B2

Function: Catalyzes the conversion of cortisol to the inactive metabolite cortisone. Modulates intracellular glucocorticoid levels, thus protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids.

Catalytic activity: An 11-beta-hydroxysteroid + NAD+ = an 11-oxosteroid + NADH.

Enzyme regulation: Inhibited by glycyrrhetinic acid (derived from liquorice), carbenoloxone and 11-alpha-OH-progesterone

By similarity.

Subunit structure: Interacts with ligand-free cytoplasmic NR3C2. Ref.12

Subcellular location: Microsome. Endoplasmic reticulum Ref.24.

Tissue specificity: Found in placenta, kidney, pancreas, prostate, ovary, small intestine and colon.

Involvement in disease: Apparent mineralocorticoid excess (AME) [MIM:218030]: An autosomal recessive form of low-renin hypertension. It is usually diagnosed within the first years of life and is characterized by polyuria and polydipsia, failure to thrive, hypernatremia, severe hypertension with low renin and aldosterone levels, profound hypokalemia with metabolic alkalosis, and most often nephrocalcinosis.Note: The disease is caused by mutations affecting the gene represented in this entry. Ref.10 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.20 Ref.21 Ref.22 Ref.23 Ref.24

Miscellaneous: Consumption of large amounts of liquorice can lead to apparent mineralocorticoid excess and hypertension.

Sequence similarities: Belongs to the short-chain dehydrogenases/reductases (SDR) family.

Biophysicochemical propertiesKinetic parameters:X.KM=26.1 nM for cortisol (Ref.23) Ref.23 Ref.24KM=785 nM for cortisol (Ref.24)KM=77 nM for cortisteroneVmax=64.1 nmol/h/mg enzyme toward cortisteroneVmax=66 nmol/h/mg enzyme toward cortisol
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000